000 01419 a2200409 4500
005 20250516123940.0
264 0 _c20130730
008 201307s 0 0 eng d
022 _a1875-9777
024 7 _a10.1016/j.stem.2012.11.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMason, Chris
245 0 0 _aThe global cell therapy industry continues to rise during the second and third quarters of 2012.
_h[electronic resource]
260 _bCell stem cell
_cDec 2012
300 _a735-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCell- and Tissue-Based Therapy
_xeconomics
650 0 4 _aClinical Trials as Topic
_xeconomics
650 0 4 _aCommerce
_xeconomics
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aHumans
650 0 4 _aInternationality
650 0 4 _aLegislation as Topic
650 0 4 _aRegenerative Medicine
_xeconomics
650 0 4 _aResearch Support as Topic
_xeconomics
650 0 4 _aUnited Kingdom
650 0 4 _aUnited States
650 0 4 _aUnited States Department of Defense
700 1 _aMcCall, Mark J
700 1 _aCulme-Seymour, Emily J
700 1 _aSuthasan, Shalini
700 1 _aEdwards-Parton, Simon
700 1 _aBonfiglio, Gregory A
700 1 _aReeve, Brock C
773 0 _tCell stem cell
_gvol. 11
_gno. 6
_gp. 735-9
856 4 0 _uhttps://doi.org/10.1016/j.stem.2012.11.013
_zAvailable from publisher's website
999 _c22325061
_d22325061